Remdesivir Induced Emergence Of Covid Variants

Ask yourself: Off the top of your head, does that sound like a good thing or a bad thing? But then, who should care? Big Pharma is making Big Money and that’s good for the country—or something like that. By the way: Do you trust your doctor?

Kevin McKernan 🙂 @Kevin_McKernan

This was entirely predicted and ignored by the Fauci censorship machine. So Pharma now has a gravy train of serial boosters plus drugs that create new variants. Liability waivers and insane reimbursement. Do you see the scam yet?

cell.comRemdesivir-induced emergence of SARS-CoV2 variants in patients with prolonged infectionHeyer et al. investigate SARS-CoV2 intra-host genomic diversity in longitudinal samples from 14 patients suffering from prolonged infection. Whereas viral populations are surprisingly stable overall, novel variant species can rapidly emerge in remdesivir-treated patients, suggesting that antiviral t…

Here’s the summary from the article:

We here investigate the impact of antiviral treatments such as remdesivir on intra-host genomic diversity and emergence of SARS-CoV2 variants in patients with a prolonged course of infection. Sequencing and variant analysis performed in 112 longitudinal respiratory samples from 14 SARS-CoV2-infected patients with severe disease progression show that major frequency variants do not generally arise during prolonged infection. However, remdesivir treatment can increase intra-host genomic diversity and result in the emergence of novel major variant species harboring fixed mutations. This is particularly evident in a patient with B cell depletion who rapidly developed mutations in the RNA-dependent RNA polymerase gene following remdesivir treatment. Remdesivir treatment-associated emergence of novel variants is of great interest in light of current treatment guidelines for hospitalized patients suffering from severe SARS-CoV2 disease, as well as the potential use of remdesivir to preventively treat non-hospitalized patients at high risk for severe disease progression.

Gotta luv that understatement, right? “Remdesivir treatment-associated emergence of novel variants is of great interest.” No shit!

Kevin McKernan 🙂 @Kevin_McKernan

You should never introduce a RdRp mutagen into a population that has non sterilizing immunization as the vaxxed patients still produce high viral loads. The mutagen + high viral loads is a variant accelerator.

Oh.

Turns out that Ralph Baric was involved:

Common sense @Commonsense0309

@Kevin_McKernan This week I read Baric was co developer of Remdesivir. These “scientists “ literally used our tax $ to create this virus and the treatments. And everything they touched is dangerous- and THEY ARE STILL ALIVE, FREE and WORKING. We are paying them

CovidCultTourGuide @CultGuide

@Commonsense0309 @Kevin_McKernan Gilead signed a contract with UNC Chapel Hill in 2014. Baric ran the Ebola Remdesivir trials as well as EIDD-2801 (Molnupiravir) in the same trial. A round 2016, Baric & Dr David Wohl went to the Congo during an Ebola outbreak and the tx options didn't work out very good

I think I’ll start holding my breath, waiting for accountability. Hmmm. I wonder how many Congress critters made big bucks investing in this sutff.